The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.
Bayer of Germany has made a takeover bid for Monsanto, potentially signaling another huge merger in the business of crop seeds and pesticides.
While the companies did not disclose details of the offer, a tie-up of the two companies would yield a giant whose products encompass antibiotics, genetically modified crop seeds and pesticides. It would have a combined annual revenue of more than $67 billion.
In a short statement late Wednesday, Monsanto said its board was reviewing the proposal. Bayer said early Thursday that it had recently met with Monsanto executives to discuss a potential deal, saying it “would create a leading integrated agriculture business.”…
As crop prices fall, analysts and investors have anticipated a flurry of deals among companies that service the farming industry. Monsanto, which failed to buy its rival Syngenta last year, has been seen as a potentially attractive takeover target.
…
Bayer and BASF had each expressed interest in exploring some kind of joint venture with Monsanto in recent months.
It was unclear whether Monsanto is interested in pursuing a sale to either Bayer or BASF. A top executive at the seed company told Reuters at an investor conference on Wednesday that talk of a deal with either company was “wild speculation.”
Read full, original post: Bayer in Talks With Monsanto Over Mega-Merger